Lori Gardner

Inhibition of Wee1 Sensitizes Cancer Cells to Antimetabolite Chemotherapeutics <i>In Vitro</i> and <i>In Vivo</i> , Independent of p53 Functionality

Annemie A. Van Linden, Dmitry Baturin, James B. Ford et al. · Molecular Cancer Therapeutics · 2013 · 128 citations · Full text

Medicine, Oncology, Pharmacology +15

A Small-Molecule Inhibitor of WEE1, AZD1775, Synergizes with Olaparib by Impairing Homologous Recombination and Enhancing DNA Damage and Apoptosis in Acute Leukemia

Tamara B. Garcia, Jonathan C. Snedeker, Dmitry Baturin et al. · Molecular Cancer Therapeutics · 2017 · 72 citations · Full text

Medicine, Oncology, Pharmacology +17

Inactivation of the p16 Cyclin-Dependent Kinase Inhibitor in High-Grade Canine Non-Hodgkin's T-Cell Lymphoma

Susan Fosmire, Rachael Thomas, Cristan M. Jubala et al. · Veterinary Pathology · 2007 · 48 citations

Medicine, Cancer Biology, Oncology +17

Inhibition of calcineurin combined with dasatinib has direct and indirect anti‐leukemia effects against BCR‐ABL1⁺ leukemia

Lori Gardner, Mark A. Gregory, Vadym Zaberezhnyy et al. · American Journal of Hematology · 2014 · 14 citations · Full text

Medicine, Oncology, Pharmacology +17

IL12 Abrogates Calcineurin-Dependent Immune Evasion during Leukemia Progression

Jennifer L. Rabe, Lori Gardner, Rae Hunter et al. · Cancer Research · 2019 · 12 citations · Full text

Life Sciences, Immunology, Oncology +17